Calidi Biotherapeutics (CLDI) Non-cash Items (2022 - 2025)

Calidi Biotherapeutics has reported Non-cash Items for 4 years, with the latest figure at $800000.0 in Q4 2025.

• For the quarter ending Q4 2025, Non-cash Items rose 15900.0% year-over-year to $800000.0; the trailing twelve-month figure through Dec 2025 stood at $800000.0 (up 15900.0% YoY), and the FY2025 full-year result was $800000.0, up 15900.0% from the prior year.
• Non-cash Items for Q4 2025 stood at $800000.0, down from $1.4 million in the prior quarter.
• The five-year high for Non-cash Items was $8.5 million in Q3 2023, with the low at $3000.0 in Q4 2023.
• Average Non-cash Items over 4 years is $2.4 million, with a median of $1.4 million recorded in 2025.
• Year-over-year, Non-cash Items tumbled 99.94% in 2023 and jumped 15900.0% in 2025.
• Tracing CLDI's Non-cash Items over 4 years: stood at $4.8 million in 2022, then plunged by 99.94% to $3000.0 in 2023, then surged by 66.67% to $5000.0 in 2024, then jumped by 15900.0% to $800000.0 in 2025.
• The last three Non-cash Items figures came in at $800000.0 (Q4 2025), $1.4 million (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.

Peer Comparison